High Grade Hepatotoxicity From Dual Checkpoint Inhibitors Is More Common in Hepatocellular Carcinoma Than Other Cancers

By afschroeder • August 9, 2025

Ennin E, Mallepally N, Ali M, Shojaie L, Dewberry S, Trieu M, Torres ETR, Zhou K, Kahn J, Dodge JL, Dara L. High Grade Hepatotoxicity From Dual Checkpoint Inhibitors Is More Common in Hepatocellular Carcinoma Than Other Cancers. Liver Int. 2025 Sep;45(9):e70255. doi: 10.1111/liv.70255. PMID: 40778804.

Tags: CTLA‐4, Digestive Diseases, Fellow, ILICI, immune‐related adverse events, immunotherapy, liver injury, PD‐1, Publications

Standardized Assessment of Complete Colorectal Polyp Resection for Polyps <20 mm (SCOPE): a Delphi Consensus

van Bokhorst QNE, Yarra S, van der Vlugt M, Pohl H, Dekker E, Shaukat A; SCOPE initiative collaborators. Standardized Assessment of Complete Colorectal Polyp Resection[...]

Assessing Treatment Response in Patients With IBS-C in Clinical Practice: Consensus Expert Recommendations Using a Modified Delphi Process

Sayuk GS, Filipenko D, Kornalska K, Swinburn P, Chang L. Assessing Treatment Response in Patients With IBS-C in Clinical Practice: Consensus Expert Recommendations Using a[...]

Hepatic stellate cell subpopulations in human MASLD-related hepatocellular carcinoma upregulate YAP via geranylgeranyl pyrophosphate

Labrecque CL, Ko A, Qiao B, Pan C, Nandakumar R, Chowdhury K, Venkatesan N, Du X, Cai B, Pellegrini M, Pisegna JR, French SW, Agopian[...]